ONCT: Oncternal Therapeutics, Inc. Yearly Stock Returns

Year	Beginning Price	Ending Price	Gain or Loss	Percent Gain or Loss
2005	13.49	7.56	-5.93	-43.96%
2006	7.56	17.84	10.28	135.98%
2007	17.84	14.35	-3.49	-19.56%
2008	14.35	16.84	2.49	17.35%
2009	16.84	4.20	-12.64	-75.06%
2010	4.20	2.65	-1.55	-36.90%
2011	2.65	3.36	0.71	26.79%
2012	3.36	4.20	0.84	25.00%
2013	4.20	1.65	-2.55	-60.71%
2014	1.65	0.73	-0.92	-55.76%
2015	0.73	0.70	-0.03	-4.11%
2016	0.70	0.528*	-0.172	-24.57%
2017	5.28	12.71	7.43	140.72%
2018	12.71	0.78	-11.93	-93.86%
2019	0.78	0.56429*	-0.21571	-27.66%
2020	3.95	4.90	0.95	24.05%
2021	4.90	2.27	-2.63	-53.67%
2022	2.27	1.00	-1.27	-55.95%
2023	1.00	0.5362	-0.4638	-46.38%

*The 2016 ending price for Oncternal Therapeutics has been adj. for a 1 for 10 reverse stock split.
*The 2019 ending price for Oncternal Therapeutics has been adj. for a 1 for 7 reverse stock split.

Calculations do not reflect any dividends paid or any stock spinoffs from original stock. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).